Monday, August 15, 2022
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Chemistry AND Physics

Danish biotech company announce the completion of a €5.5 million seed investment

March 22, 2019
in Chemistry AND Physics
0
Share on FacebookShare on Twitter

The big Chinese fine chemical company Zhejiang NHU invest €5.5 million in the biotech start-up CysBio to develop new and affordable biochemicals

IMAGE

Credit: The Novo Nordisk Foundation Center for Biosustainability (DTU)/CysBio

CysBio is making cost-effective and novel biochemicals via sustainable fermentation processes. Through advanced synthetic biology and metabolic engineering approaches microorganisms are engineered to convert simple sugars into desired biochemical products. This makes it possible to produce expensive chemicals at very attractive cost levels and furthermore enables the production of novel or rare biochemicals.

The products will have applications in a variety of areas such as the food, feed, nutrition, pharma, cosmetics, and polymer industries.

“Our technologies enable CysBio to create some of the cheapest biochemicals available, as well as some very exciting new products with novel applications as functional chemical building blocks,” says Alex Toftgaard Nielsen, CSO and Co-founder of CysBio and Professor at DTU Biosustain.

Based on scientific research from DTU

CysBio’s technologies are patented and based on scientific research conducted at the Novo Nordisk Foundation Center for Biosustainability at the Technical University of Denmark. This research has made it possible to modify and engineer the bacteria’s metabolism, thus, making them able to produce specific amino acids and sulfated biochemicals.

“The investment from NHU demonstrates how DTU’s innovation eco-system has successfully assisted in translating academic research into a privately funded spin-out company with a strong technology platform,” says Marianne Thellersen, Senior Vice President for Innovation and Entrepreneurship at DTU.

Big unexploited potential

The technology platform paves the way for producing compounds used for e.g. new polymer materials with new functionalities such as conductivity and adhesiveness. Products that are highly demanded by the chemical industry. One of the other biochemicals that CysBio works with is well-known from nature as an alternative to chemically produced pesticides to prevent the growth of bacteria and fungus on surfaces of various kinds. Thus, CysBio expects to produce greener alternatives that can replace the use of harsh chemicals in many different market segments.

“We aim at becoming a leading provider of functional biochemical monomers and the partnership with a leading company like Zhejiang NHU will allow a fast market introduction of parts of this technology. Our strategy will clearly be to enables our technologies to be exploited quickly and effectively through R&D and commercial partnerships,” says Henrik Meyer, CEO and Co-founder of CysBio.

The Danish biotech company plans to get their first products on the market already at the beginning of 2020.

Future perspectives for pharma

Some of the key targets for the proprietary sulfation technology will be methods for improving the solubility and bioavailability of some existing drugs and nutraceuticals, thereby increasing the efficacy of the drugs.

“This will help in solving the problem of developing new pharmaceuticals, so we also see great potential in collaborating closely with partners in the pharma industry, “says Alex Toftgaard Nielsen.

Expands portfolio of products

For the stock listed Chinese chemical company, Zhejiang NHU, with global operations and subsidiaries in Europe, the seed investment in CysBio also opens up for exploring new opportunities in the market.

“We strongly believe the future of biotechnology. We have great strategic interests in expanding our biotechnology-based product portfolio by partnering with biotechnology companies. We look forward to assisting CysBio in their growth and further product development.” says Mr. Bai Fan Hu, Chairman of Zhejiang NHU.

###

Media Contact
Anders Osterby Moensted
[email protected]

Tags: BiochemistryBiologyBiomedical/Environmental/Chemical EngineeringBiotechnologyCollaborationGrants/FundingIndustrial Engineering/Chemistry
Share25Tweet16Share4ShareSendShare
  • Amanda Poholek, Ph.D.

    Reinvigorating ‘lost cause’ exhausted T cells could improve cancer immunotherapy

    136 shares
    Share 54 Tweet 34
  • Nuclear war would cause a global famine and kill billions, Rutgers-led study finds

    65 shares
    Share 26 Tweet 16
  • The best way to take pills according to science

    65 shares
    Share 26 Tweet 16
  • 1 in 3 parents worry that school traffic is a danger for kids

    65 shares
    Share 26 Tweet 16
  • Exercise answer: Research shows it’s how often you do it, not how much

    64 shares
    Share 26 Tweet 16
  • Null results research now published by major behavioral medicine journal

    384 shares
    Share 154 Tweet 96
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Reinvigorating ‘lost cause’ exhausted T cells could improve cancer immunotherapy

Experts optimistic about converting coal plants to production of clean geothermal energy

A role for cell ‘antennae’ in managing dopamine signals in the brain

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 193 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In